Health Status and the Spiral of Decline

COPD is complex and there are multiple determinants of poor health, so most studies of Chronic Obstructive Pulmonary Disease (COPD) now include health status, or health related quality of life measurement, along with FEV1 as a primary endpoint. It is important to make a distinction between quality of life—which is unique to the individual, and health status measurement—which is standardized quantification of the impact of disease. Health status scores correlate weakly with FEV1 but they are predictors of mortality independently of age and FEV1. The determinants of impaired health status may change over time and the clinical consequences associated with a given change in score may change with disease progression. The largest study to date suggests that health status decline is linear over time, but longer-term studies are needed to confirm these findings. Inhaled corticosteroids have been shown to reduce the rate of decline of health status, possibly due to exacerbation prevention.

[1]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[2]  P. Jones,et al.  Outcomes and markers in the assessment of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.

[3]  V. Brusasco,et al.  Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. , 2003, Thorax.

[4]  D. Niewoehner,et al.  Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator , 2005, Annals of Internal Medicine.

[5]  John R Hurst,et al.  Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.

[6]  A. Clément,et al.  Task force on chronic interstitial lung disease in immunocompetent children , 2004, European Respiratory Journal.

[7]  S. Spencer,et al.  Impact of preventing exacerbations on deterioration of health status in COPD , 2004, European Respiratory Journal.

[8]  Sally J. Singh,et al.  Development of a Shortened Version of the Breathing Problems Questionnaire Suitable for Use in a Pulmonary Rehabilitation Clinic: A Purpose-Specific, Disease-Specific Questionnaire , 1998, Quality of Life Research.

[9]  M. Hyland,et al.  Domains, constructs and the development of the breathing problems questionnaire , 1994, Quality of Life Research.

[10]  S. Spencer,et al.  Withdrawal from treatment as an outcome in the ISOLDE study of COPD. , 2003, Chest.

[11]  M. Tsukino,et al.  Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. , 2003, American journal of respiratory and critical care medicine.

[12]  V. Brusasco,et al.  Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. , 2003, Thorax.

[13]  Jordi Alonso,et al.  Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[14]  R. Zuwallack,et al.  A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.

[15]  J. V. van Noord,et al.  Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.

[16]  P. Jones,et al.  Health status measurement in chronic obstructive pulmonary disease , 2001, Thorax.

[17]  R. Zuwallack,et al.  Quality of Life Evaluation and Survival Study: a 3-yr prospective multinational study on patients with chronic respiratory failure. , 2001, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[18]  P M Calverley,et al.  Health status deterioration in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[19]  P. Jones,et al.  Analysis of factors that characterize health impairment in patients with chronic respiratory failure , 1999 .

[20]  P. Jones,et al.  Analysis of factors that characterize health impairment in patients with chronic respiratory failure. Quality of Life in Chronic Respiratory Failure Group. , 1999, The European respiratory journal.

[21]  M. Tsukino,et al.  Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[22]  J. Dijkman,et al.  The development of the 'Quality-of-life for Respiratory Illness Questionnaire (QOL-RIQ)': a disease-specific quality-of-life questionnaire for patients with mild to moderate chronic non-specific lung disease. , 1997, Respiratory medicine.

[23]  P. Jones,et al.  Quality of life changes in COPD patients treated with salmeterol. , 1997, American journal of respiratory and critical care medicine.

[24]  M. Sullivan,et al.  Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study. , 1996, Thorax.

[25]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[26]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[27]  G. Guyatt,et al.  A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.